- Home
- PCVX vs EVR Comparison
PCVX vs EVR Comparison
Compare PCVX & EVR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PCVX
- EVR
- Stock Information
- Founded
- PCVX 2013
- EVR 1995
- Country
- PCVX United States
- EVR United States
- Employees
- PCVX N/A
- EVR N/A
- Industry
- PCVX Biotechnology: Pharmaceutical Preparations
- EVR Investment Managers
- Sector
- PCVX Health Care
- EVR Finance
- Exchange
- PCVX Nasdaq
- EVR Nasdaq
- Market Cap
- PCVX 13.2B
- EVR 10.8B
- IPO Year
- PCVX 2020
- EVR 2006
- Fundamental
- Price
- PCVX $85.30
- EVR $282.62
- Analyst Decision
- PCVX Strong Buy
- EVR Hold
- Analyst Count
- PCVX 9
- EVR 6
- Target Price
- PCVX $149.38
- EVR $289.60
- AVG Volume (30 Days)
- PCVX 1.2M
- EVR 353.2K
- Earning Date
- PCVX 02-25-2025
- EVR 01-29-2025
- Dividend Yield
- PCVX N/A
- EVR 1.13%
- EPS Growth
- PCVX N/A
- EVR N/A
- EPS
- PCVX N/A
- EVR 7.79
- Revenue
- PCVX N/A
- EVR $2,789,086,000.00
- Revenue This Year
- PCVX N/A
- EVR $21.40
- Revenue Next Year
- PCVX N/A
- EVR $22.72
- P/E Ratio
- PCVX N/A
- EVR $36.28
- Revenue Growth
- PCVX N/A
- EVR 12.78
- 52 Week Low
- PCVX $58.10
- EVR $168.04
- 52 Week High
- PCVX $121.06
- EVR $324.06
- Technical
- Relative Strength Index (RSI)
- PCVX 48.31
- EVR 52.96
- Support Level
- PCVX $77.52
- EVR $257.35
- Resistance Level
- PCVX $89.65
- EVR $283.49
- Average True Range (ATR)
- PCVX 3.95
- EVR 6.32
- MACD
- PCVX 0.77
- EVR 1.13
- Stochastic Oscillator
- PCVX 62.04
- EVR 96.67
About PCVX Vaxcyte Inc.
Vaxcyte Inc is a vaccine company seeking to improve global health by developing novel vaccines to treat patients suffering from the most common and deadly diseases. Its product comprises. of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-24, VAX-A1, and VAX-PG.
About EVR Evercore Inc.
Evercore is an independent investment bank that derives the majority of its revenue from financial advisory, including merger, acquisition, and restructuring advisory. It also has institutional equities trading, equity underwriting, and investment management businesses that account for around 20% of net revenue. The company was founded in 1996 and went public in 2006. Evercore had approximately 2,200 employees at the end of 2023, and about 75% of its revenue is derived from the United States.